Open Access Repository
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Downloads
Downloads per month over past year
![]() |
PDF
4067.pdf | Request a copy Full text restricted |
Abstract
Sarcoidosis is a common, multi system, granulomatous disorder
with frequent lung involvement that can in some cases progress
to pulmonary fibrosis. The severity of the lung involvement is assessed
on the basis of the patient’s symptoms (particularly dyspnoea
and cough), changes on the chest x-ray (CXR) and on deteriorating
lung function. High resolution CT scans are now important
in differentiating sarcoid from other interstitial lung diseases.
Patientsmay also complain of systemic symptoms such as lethargy.
Involvement of other organs including liver, skin and brain is also
common in this group of patients. Oral corticosteroids are often
prescribed first in such cases. Immunosuppressives and cytotoxic
agents are also prescribed for those who do not respond to steroids
and show a progressive deterioration or to those who are unable
to tolerate steroids (steroid sparing agents).
Item Type: | Article |
---|---|
Authors/Creators: | Paramothayan, PJ and Lasserson, TJ and Walters, EH |
Journal or Publication Title: | Cochrane Database of Systematic Reviews |
Publisher: | Wiley-Liss, Div John Wiley & Sons Inc |
ISSN: | 1469-493X |
DOI / ID Number: | 10.1002/14651858.CD003536.pub2. |
Additional Information: | Copyright © 2008 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd |
Item Statistics: | View statistics for this item |
Actions (login required)
![]() |
Item Control Page |